Cohen Fred E
SEC-identified person · CIK 1339358 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Caredx, Inc. CDNA | Director | filed 2014 - 2026 |
| Intellia Therapeutics, Inc. NTLA | Director | filed 2019 - 2026 |
| Kyverna Therapeutics, Inc. KYTX | Director | filed 2024 - 2026 |
| Urogen Pharma Ltd. URGN | Director | filed 2019 - 2024 |
| Progyny, Inc. PGNY | Director | filed 2019 - 2024 |
| Veracyte, INC. VCYT | Director | filed 2013 - 2020 |
| Genomic Health INC GHDX | Director | filed 2006 - 2019 |
| Tandem Diabetes Care INC TNDM | Director | filed 2013 - 2018 |
| Biocryst Pharmaceuticals INC BCRX | Director | filed 2013 - 2018 |
| Roka Bioscience, Inc. ROKA | Director | filed 2014 - 2017 |
| Five Prime Therapeutics, INC. FPRX | Director | filed 2013 - 2017 |
| Quintiles Transnational Holdings Inc. Q | Director | filed 2013 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.